Bin Jiang
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 45
- Chronic Myeloid Leukemia Treatments 28
- Multiple Myeloma Research and Treatments 9
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Oncology top 10%
- Molecular Biology top 10%
- Retinoids in leukemia and cellular processes 13
-
- Acute Lymphoblastic Leukemia research 22
-
- Eosinophilic Disorders and Syndromes 11
- Co-authors
- Xiao‐Jun HuangYanrong LiuShanshan ChenKai‐Yan LiuYa‐Zhen QinQian JiangHao JiangHong‐Hu Zhu
- Cited by
- HematologyGeneticsOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bin Jiang
90 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Hematology 1.2k
- Genetics 330
- Oncology 365
- Molecular Biology 709
- Public Health, Environmental and Occupational Health 299
Countries citing papers authored by Bin Jiang
This map shows the geographic impact of Bin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Jiang more than expected).
Fields of papers citing papers by Bin Jiang
This network shows the impact of papers produced by Bin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Jiang. The network helps show where Bin Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 49 | |
| 7 | 2017 | 1 | |
| 8 | 2017 | 3 | |
| 9 | 2016 | 12 | |
| 10 | 2015 | 15 | |
| 11 | 2014 | 8 | |
| 12 | Development and application of a loop-mediated isothermal amplification assay for visual detection of Haemophilus parasuis. | 2013 | 1 |
| 13 | 2012 | 11 | |
| 14 | 2012 | 22 | |
| 15 | Establishment and its application of RT-PCR for detection of novel duck reovirus. | 2011 | 3 |
| 16 | Detection of duck circovirus infection. | 2010 | 1 |
| 17 | Cloning and sequence analysis of a new dehydrin gene (WZY2) from wheat. | 2009 | 6 |
| 18 | 2008 | 3 | |
| 19 | Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR. | 2007 | 5 |
| 20 | Detection of muscovy duck reovirus by RT-PCR | 2004 | 2 |
About Bin Jiang
Bin Jiang is a scholar working on Hematology, Genetics, Emergency Medicine, Public Health, Environmental and Occupational Health and Rheumatology, having authored 94 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (45 papers), Chronic Myeloid Leukemia Treatments (28 papers), Acute Lymphoblastic Leukemia research (22 papers), Chronic Lymphocytic Leukemia Research (16 papers), Retinoids in leukemia and cellular processes (13 papers), Eosinophilic Disorders and Syndromes (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (9 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (330 citations), Oncology (365 citations), Molecular Biology (709 citations) and Public Health, Environmental and Occupational Health (299 citations). Bin Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiao‐Jun Huang, Yanrong Liu, Shanshan Chen, Kai‐Yan Liu, Ya‐Zhen Qin, Qian Jiang, Hao Jiang, Hong‐Hu Zhu, Jing Yuan and Yue‐Yun Lai. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, British Journal of Haematology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.